Using the online database GEPIA2, we found that the correlation between CASP4 expression levels and poor glioma prognosis (OS and DFS) was the most significant, suggesting that CASP4 plays a critical role in the prognosis of glioma treatment. Here, CASP4 is linked to glioma.